Results 31 to 40 of about 43,187 (251)

Bronchial artery embolisation in management of hemoptysis – A retrospective analysis in a tertiary university hospital

open access: yesRevista Portuguesa de Pneumologia (English Edition), 2016
Background: Bronchial artery embolisation (BAE) becomes a mainstay in the treatment of hemoptysis. Objective: To characterise patients with hemoptysis undergoing bronchial artery angiography (BAA) for embolisation, evaluating outcomes.
H. Dabó   +5 more
doaj   +1 more source

A retrospective analysis of risk factors for massive hemoptysis in patients with bronchiectasis

open access: yesBMC Pulmonary Medicine, 2022
Background Massive hemoptysis is a common and fatal complication of bronchiectasis. However, the risk factors for massive hemoptysis in patients with bronchiectasis have not yet been reported.
Ling Luo, Jing Luo, Yu Jiang
doaj   +1 more source

Hydatid Cyst in a Post-Tuberculosis Patient: A Persistent Pulmonary Puzzle - A Case Report. [PDF]

open access: yesClin Case Rep
ABSTRACT Pulmonary tuberculosis and hydatid cyst are two distinct pathologies with vastly different etiologies and management approaches, yet they share common risk factors and pulmonary involvement. This rare and unique case of a hydatid cyst occurring in a post‐tuberculosis patient adds to the limited literature and highlights the diagnostic and ...
Shahid AR   +9 more
europepmc   +2 more sources

The Application Value of Bronchoalveolar Lavage Fluid Metagenomic Next‐Generation Sequencing in Moderate‐to‐Severe Bronchiectasis

open access: yesJournal of Clinical Laboratory Analysis, EarlyView.
This study analyzed the clinical data of 52 patients with moderate‐to‐severe bronchiectasis who were admitted to our hospital. It explored the diagnostic value of bronchoalveolar lavage fluid (BALF) metagenomic next‐generation sequencing (mNGS) in identifying infectious pathogens in patients with moderate‐to‐severe bronchiectasis, and clarified the ...
Jiachun Li   +6 more
wiley   +1 more source

Integrating Clinical Features, Laboratory Biomarkers and Computed Tomography for the Discrimination of Non‐Small Cell Lung Cancer and Benign Pulmonary Diseases: A Clinical Prediction Model

open access: yesJournal of Clinical Laboratory Analysis, EarlyView.
This study developed and validated a clinical prediction model to differentiate non‐small cell lung cancer (NSCLC) from benign pulmonary diseases using clinical features, laboratory biomarkers, and CT features. The model achieved an AUC‐ROC of 0.95 in the training set and 0.82 in the validation set, demonstrating reliable diagnostic performance and ...
Jie Zhang   +5 more
wiley   +1 more source

Clinical characteristics and anticoagulation patterns of patients with acute pulmonary thromboembolism and hemoptysis

open access: yesPulmonary Circulation
Hemoptysis is a frequently encountered manifestation in cases of acute pulmonary thromboembolism (PTE), significantly impacting clinical decision‐making.
Yiyao Li   +5 more
doaj   +1 more source

Risk Factors for a Second Episode of Hemoptysis

open access: yesClinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, 2009
Objectives Hemoptysis is an alarming symptom of underlying lung disease. Clinicians are often unsure how to deal with and follow up patients who have had a single episode of hemoptysis, especially if the cause remains unknown despite thorough examination,
Nobuhiko Seki   +7 more
doaj   +1 more source

Vascular Supply of Laryngeal Paragangliomas: Case Report and Systematic Review

open access: yesWorld Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Objective Laryngeal paragangliomas are rare, highly vascularized, neuroendocrine tumors. Although surgical resection of these vascular neoplasms is associated with a known risk of significant hemorrhage, the vascular supply of laryngeal paragangliomas has been poorly characterized. Data Sources MEDLINE Ovid, Embase, Scopus, and Google Scholar.
Jane Y. Tong   +3 more
wiley   +1 more source

Lung squamous cell carcinoma with hemoptysis after vaccination with tozinameran (BNT162b2, Pfizer‐BioNTech) [PDF]

open access: gold, 2021
Toshiyuki Sumi   +6 more
openalex   +1 more source

Obstetric and Neonatal Outcomes in Pregnancies From a Dedicated Cystic Fibrosis‐Maternal Health Service: A Retrospective Study

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective A comprehensive review of maternal, obstetric and neonatal outcomes in pregnancies in females with cystic fibrosis (fwCF) following the introduction of Elexacaftor/Tezacaftor/Ivacaftor (ETI) therapy in a novel, dedicated CF‐Maternal Health service.
Rebecca Scott   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy